ARTEMIS highlights VEGF inhibitors as effective partners for EGFR TKIs in EGFR mutant NSCLC. Le X, Nilsson MB, Robichaux JP, Heymach JV, et al. Cancer Cell 2021;39:1178-1180.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Le X, Nilsson MB, Robichaux JP, Heymach JV, et al. ARTEMIS highlights VEGF inhibitors as effective partners for EGFR TKIs in EGFR mutant NSCLC. Cancer Cell 2021;39:1178-1180.
PMID: 34388379